Users of this system, can login to view this document.
Login
Enter the following information to request a copy of the document from the responsible person.
First-in-Human Phase I Study of an Oral HSP90 Inhibitor, TAS-116, in Patients with Advanced Solid Tumors.
This email address is used for sending the document.